NAD+ IV Therapy and the Biology of Aging Why a molecule you have never heard of decreases as you get older

Somewhere in your forties a molecule called NAD+ starts running low, and almost every cell depends on it. It turns food into energy, powers DNA repair, and keeps longevity enzymes switched on. By middle age it has dropped by at least half, which is why NAD+ IV therapy is everywhere in longevity medicine.

What NAD+ Does Inside the Cell

NAD+ stands for nicotinamide adenine dinucleotide, and it shuttles electrons through the reactions that pull energy from glucose and fat into your mitochondria. Without it, those engines sputter.

It has a second job that matters just as much for aging. Three families of enzymes do not merely use NAD+, they spend it.

• Sirtuins. Longevity enzymes that tune metabolism, the stress response, and the body clock, spending NAD+ every time they work.
• PARPs. Your DNA repair crews. Every break they flag for repair costs NAD+, so decades of damage run the bill up.
• CD38. A consumer with no off switch, chewing through NAD+ as part of immune signaling and rising with age.

NAD+ levels decline during aging and may be an Achilles' heel, causing defects in nuclear and mitochondrial functions due to reduced sirtuin activity.

Imai & Guarente, Trends in Cell Biology, 2014

Why NAD+ Declines With Age

NAD+ decline is supply and demand drifting apart. Aging widens the drains and narrows the inflow at the same time.

On the demand side the biggest culprit is CD38, which rises across liver, fat, and muscle in aging mice as NAD+ falls. It also destroys NMN, the building block of NAD+.

The other drain is repair itself, since PARP enzymes fire more often as DNA damage accumulates. The salvage pathway that recycles NAD+ also slows with age.

Oral Precursors: What NMN and NR Actually Do in People

You cannot simply swallow NAD+, because it does not survive digestion. The supplement world reaches for two precursors, NMN and NR, which the cell rebuilds into NAD+.

The biochemical evidence is good. In a placebo-controlled trial in older adults, NR at one gram a day raised blood NAD+ roughly 2.6-fold over ten weeks, and an NMN trial found similar increases.

Raising a number in your blood is not the same as getting healthier. In that NR trial, cognition had not improved over placebo even though NAD+ had climbed sharply.

• Oral NMN and NR reliably raise blood NAD+, often by twofold or more.
• They are safe and well tolerated over weeks to months at the doses studied.
• Proof that they slow disease or extend health span in humans does not yet exist.

Why Some Clinics Use NAD+ IV Therapy Instead

If a pill raises blood NAD+ fine, why run an infusion? The argument for NAD+ IV therapy is the route, since an IV skips the gut and pushes a large dose straight into the bloodstream.

The biology is more stubborn. In the most detailed human study, blood NAD+ did not budge for the first two hours of a six-hour infusion. Most cells absorb smaller pieces and rebuild NAD+ inside.

What We Can Honestly Say Today

NAD+ is central to aging biology and falls with age, and on that the evidence is robust. Oral precursors clearly raise it and look safe short term, but the long-term benefits have not been demonstrated and IV NAD+ is earlier still. If you are weighing NAD+ IV therapy in West Hollywood, treat it as a promising tool still under study.